Log In
Print
BCIQ
Print
Print this Print this
 

VCN-01

  Manage Alerts
Collapse Summary General Information
Company VCN Biosciences S.L.
DescriptionModified adenovirus serotype 5 (Ad5) designed to replicate only in tumors and to degrade hyaluronan in tumor stroma
Molecular Target
Mechanism of ActionOncolytic virus
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today